206 related articles for article (PubMed ID: 22064520)
1. The role of mucin in GERD and its complications.
Niv Y; Fass R
Nat Rev Gastroenterol Hepatol; 2011 Nov; 9(1):55-9. PubMed ID: 22064520
[TBL] [Abstract][Full Text] [Related]
2. Mucin expression profile in Barrett's, dysplasia, adenocarcinoma sequence in the esophagus.
Burjonrappa SC; Reddimasu S; Nawaz Z; Gao X; Sharma P; Loggie B
Indian J Cancer; 2007; 44(1):1-5. PubMed ID: 17401217
[TBL] [Abstract][Full Text] [Related]
3. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis of reflux esophagitis and Barrett's esophagus.
Orlando RC
Med Clin North Am; 2005 Mar; 89(2):219-41, vii. PubMed ID: 15656926
[TBL] [Abstract][Full Text] [Related]
5. The integrity of the esophageal mucosa. Balance between offensive and defensive mechanisms.
Orlando RC
Best Pract Res Clin Gastroenterol; 2010 Dec; 24(6):873-82. PubMed ID: 21126700
[TBL] [Abstract][Full Text] [Related]
6. Mucin expression and proliferating cell index of esophageal Barrett's adenocarcinoma.
Yamamoto S; Kijima H; Hara T; Chino O; Shimada H; Tanaka M; Inokuchi S; Makuuchi H
Int J Mol Med; 2005 Sep; 16(3):375-80. PubMed ID: 16077942
[TBL] [Abstract][Full Text] [Related]
7. Expression of MUC1 and MUC2 mucin gene products in Barrett's metaplasia, dysplasia and adenocarcinoma: an immunopathological study with clinical correlation.
Chinyama CN; Marshall RE; Owen WJ; Mason RC; Kothari D; Wilkinson ML; Sanderson JD
Histopathology; 1999 Dec; 35(6):517-24. PubMed ID: 10583575
[TBL] [Abstract][Full Text] [Related]
8. Mucin gene expression and cell differentiation in human normal, premalignant and malignant esophagus.
Guillem P; Billeret V; Buisine MP; Flejou JF; Lecomte-Houcke M; Degand P; Aubert JP; Triboulet JP; Porchet N
Int J Cancer; 2000 Dec; 88(6):856-61. PubMed ID: 11093805
[TBL] [Abstract][Full Text] [Related]
9. Esophageal mucin: an adherent mucus gel barrier is absent in the normal esophagus but present in columnar-lined Barrett's esophagus.
Dixon J; Strugala V; Griffin SM; Welfare MR; Dettmar PW; Allen A; Pearson JP
Am J Gastroenterol; 2001 Sep; 96(9):2575-83. PubMed ID: 11569678
[TBL] [Abstract][Full Text] [Related]
10. E-cadherin expression in gastroesophageal reflux disease, Barrett's esophagus, and esophageal adenocarcinoma: an immunohistochemical and immunoblot study.
Swami S; Kumble S; Triadafilopoulos G
Am J Gastroenterol; 1995 Oct; 90(10):1808-13. PubMed ID: 7572899
[TBL] [Abstract][Full Text] [Related]
11. Pathophysiology of Barrett's esophagus.
Chandrasoma P
Semin Thorac Cardiovasc Surg; 1997 Jul; 9(3):270-8. PubMed ID: 9263345
[TBL] [Abstract][Full Text] [Related]
12. P53 and Ki-67 overexpression in gastroesophageal reflux disease--Barrett's esophagus and adenocarcinoma sequence.
Binato M; Gurski RR; Fagundes RB; Meurer L; Edelweiss MI
Dis Esophagus; 2009; 22(7):588-95. PubMed ID: 19302208
[TBL] [Abstract][Full Text] [Related]
13. Molecular pathways: pathogenesis and clinical implications of microbiome alteration in esophagitis and Barrett esophagus.
Yang L; Francois F; Pei Z
Clin Cancer Res; 2012 Apr; 18(8):2138-44. PubMed ID: 22344232
[TBL] [Abstract][Full Text] [Related]
14. [Expression of c-myb in reflux esophagitis, Barrett esophagus and esophageal adenocarcinoma].
Ren CR; Dong L; Guo XY
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Dec; 30(12):2693-5. PubMed ID: 21177182
[TBL] [Abstract][Full Text] [Related]
15. Mucin core polypeptide expression in the progression of neoplasia in Barrett's esophagus.
Glickman JN; Blount PL; Sanchez CA; Cowan DS; Wongsurawat VJ; Reid BJ; Odze RD
Hum Pathol; 2006 Oct; 37(10):1304-15. PubMed ID: 16949933
[TBL] [Abstract][Full Text] [Related]
16. How to make a Barrett esophagus: pathophysiology of columnar metaplasia of the esophagus.
Guillem PG
Dig Dis Sci; 2005 Mar; 50(3):415-24. PubMed ID: 15810619
[TBL] [Abstract][Full Text] [Related]
17. Divergent expression of MUC5AC, MUC6, MUC2, CD10, and CDX-2 in dysplasia and intramucosal adenocarcinomas with intestinal and foveolar morphology: is this evidence of distinct gastric and intestinal pathways to carcinogenesis in Barrett Esophagus?
Khor TS; Alfaro EE; Ooi EM; Li Y; Srivastava A; Fujita H; Park Y; Kumarasinghe MP; Lauwers GY
Am J Surg Pathol; 2012 Mar; 36(3):331-42. PubMed ID: 22261707
[TBL] [Abstract][Full Text] [Related]
18. Pulsatile exposure to simulated reflux leads to changes in gene expression in a 3D model of oesophageal mucosa.
Green NH; Nicholls Z; Heath PR; Cooper-Knock J; Corfe BM; MacNeil S; Bury JP
Int J Exp Pathol; 2014 Jun; 95(3):216-28. PubMed ID: 24713057
[TBL] [Abstract][Full Text] [Related]
19. The esophageal mucosa and submucosa: immunohistology in GERD and Barrett's esophagus.
Appelman HD; Streutker C; Vieth M; Neumann H; Neurath MF; Upton MP; Sagaert X; Wang HH; El-Zimaity H; Abraham SC; Bellizzi AM
Ann N Y Acad Sci; 2013 Oct; 1300():144-165. PubMed ID: 24117640
[TBL] [Abstract][Full Text] [Related]
20. Characterization of acid and alkaline reflux in patients with Barrett's esophagus. G.O.S.P.E. Operative Group for the study of Esophageal Precancer.
D'Onofrio V; Bovero E; Iaquinto G
Dis Esophagus; 1997 Jan; 10(1):16-22; discussion 22-3. PubMed ID: 9079268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
